Aceon

Congestive heart failure, Hypesthesia, Hypesthesia + 9 more
Treatment
10 FDA approvals
20 Active Studies for Aceon

What is Aceon

PerindoprilThe Generic name of this drug
Treatment SummaryPerindopril is a medication used to lower blood pressure and reduce cardiovascular risk in people with hypertension or coronary heart disease. It belongs to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. Perindopril is taken orally and is quickly converted to its active metabolite, perindoprilat, which works by blocking the enzyme responsible for converting angiotensin I to angiotensin II. By blocking this enzyme, Perindopril helps to regulate blood pressure and maintain a healthy balance of hormones in the body.
Aceonis the brand name
image of different drug pills on a surface
Aceon Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Aceon
Perindopril
1993
33

Approved as Treatment by the FDA

Perindopril, also known as Aceon, is approved by the FDA for 10 uses like Hypertension, Essential Hypertension and NYHA Class I Congestive heart failure .
Hypertension, Essential Hypertension
Helps manage Hypertension, Essential Hypertension
NYHA Class I Congestive heart failure
Helps manage NYHA Class I Congestive heart failure
Hypesthesia
Helps manage chronic heart failure with reduced ejection fraction (NYHA Class II)
Stroke
Used to treat Cerebrovascular Accident in combination with Amlodipine
perindopril
Used to treat inadequate response on perindopril monotherapy in combination with Amlodipine
Hypertensive disease
Used to treat High Blood Pressure (Hypertension) in combination with Amlodipine
Hypertensive disease
Helps manage Hypertension, Essential Hypertension
Congestive heart failure
Helps manage NYHA Class I Congestive heart failure
Heart Attack
Used to treat Myocardial Infarction in combination with Amlodipine
Hypesthesia
Helps manage chronic heart failure with reduced ejection fraction (NYHA Class III)

Effectiveness

How Aceon Affects PatientsPerindopril is a drug that works by blocking the enzyme (angiotensin II) and hormone system (renin angiotensin aldosterone system, or RAAS) that regulates blood pressure and water balance in the body. It works by inhibiting the conversion of angiotensin I to angiotensin II, which has numerous effects on the body including increasing blood pressure, increasing sodium and water reabsorption from the kidneys, stimulating the secretion of vasopressin, and inducing thirst. Additionally, it prevents the breakdown of bradykinin, a vasodilator which helps further reduce blood
How Aceon works in the bodyACE inhibitors work by blocking an enzyme called ACE. This enzyme has two parts, called N and C domains, which have similar roles. The C domain is mainly responsible for controlling blood pressure, and the N domain helps with stem cell development. Perindopril, the active form of ACE inhibitor, stops ACE from binding to another protein, called ATI. This lowers the amount of ATI in the body, which in turn lowers blood pressure. Perindopril also increases the amount of renin in the body, which can help to regulate blood pressure.

When to interrupt dosage

The measure of Aceon is contingent upon the recognized disorder, for example, Hypertensive disease, Hypesthesia and Hypesthesia. The amount of dosage fluctuates as per the method of delivery (e.g. Tablet or Oral) featured in the table beneath.
Condition
Dosage
Administration
Hypesthesia
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Hypesthesia
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Cardiovascular Events
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Diabetic Nephropathies
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Stroke
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Heart Attack
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Hypertensive disease
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
High Cardiovascular Risk
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Hypertensive disease
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
perindopril
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
adequately controlled by simultaneous administration of component drugs
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating
Congestive heart failure
, 4.0 mg, 8.0 mg, 2.0 mg, 2.5 mg, 5.0 mg, 10.0 mg, 3.5 mg, 14.0 mg, 7.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating

Warnings

Aceon Contraindications
Condition
Risk Level
Notes
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Type 2 Diabetes
Do Not Combine
There are 20 known major drug interactions with Aceon.
Common Aceon Drug Interactions
Drug Name
Risk Level
Description
Amifostine
Major
Perindopril may increase the hypotensive activities of Amifostine.
Azathioprine
Major
The risk or severity of myelosuppression, anemia, and severe leukopenia can be increased when Perindopril is combined with Azathioprine.
Lithium carbonate
Major
The serum concentration of Lithium carbonate can be increased when it is combined with Perindopril.
Lithium citrate
Major
The serum concentration of Lithium citrate can be increased when it is combined with Perindopril.
Lithium hydroxide
Major
The serum concentration of Lithium hydroxide can be increased when it is combined with Perindopril.
Aceon Toxicity & Overdose RiskOverdosing on Telmisartan can lead to dangerously low blood pressure, as well as coughing, stomach problems, tiredness, headaches, and dizziness.
image of a doctor in a lab doing drug, clinical research

Aceon Novel Uses: Which Conditions Have a Clinical Trial Featuring Aceon?

Currently, 112 active studies are being conducted to assess the potential of Aceon to alleviate Hypesthesia, Hypertensive Disease and Heart Attack.
Condition
Clinical Trials
Trial Phases
Diabetic Nephropathies
0 Actively Recruiting
Cardiovascular Events
4 Actively Recruiting
Not Applicable
Stroke
6 Actively Recruiting
Not Applicable, Phase 1
Hypesthesia
8 Actively Recruiting
Not Applicable, Phase 1
Congestive heart failure
0 Actively Recruiting
Hypesthesia
2 Actively Recruiting
Not Applicable
High Cardiovascular Risk
2 Actively Recruiting
Phase 2, Phase 3
Hypertensive disease
27 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3
Hypertensive disease
3 Actively Recruiting
Not Applicable, Phase 3
Heart Attack
23 Actively Recruiting
Not Applicable, Phase 1, Phase 4, Phase 2, Early Phase 1, Phase 3
adequately controlled by simultaneous administration of component drugs
0 Actively Recruiting
perindopril
0 Actively Recruiting

Aceon Reviews: What are patients saying about Aceon?

5Patient Review
8/7/2009
Aceon for High Blood Pressure
I've been using Aceon for over five years and it's always kept my blood pressure at a healthy level. The only downside is that I sometimes cough while taking it, but that's not enough to deter me from using this great medication.
5Patient Review
4/7/2013
Aceon for High Blood Pressure
I had no problems with the medication. However, I was informed by the pharmacist that it is no longer available. I was switched to Lisinopril and it has been just as effective in controlling my hypertension.
5Patient Review
9/28/2007
Aceon for High Blood Pressure
4.7Patient Review
9/26/2007
Aceon for High Blood Pressure
4Patient Review
3/17/2008
Aceon for High Blood Pressure
After using this treatment, I no longer feel light-headed or pressure when standing up or reading.
3Patient Review
5/1/2012
Aceon for High Blood Pressure
I'm pretty sure I'm taking the generic form, and it has made me gain a lot of weight. 10 lbs in 6 months, then 8 lbs in 6 months. I've always been a size 8, sometimes size 6 and now I am wearing 10s and 12s...what is going on?????
3Patient Review
6/24/2008
Aceon for Chronic Heart Failure
I experienced some lower leg swelling, but no other adverse reactions.
2.7Patient Review
3/4/2013
Aceon for High Blood Pressure
I've been taking the generic form of Aceon for insurance purposes, and I'm certain that it's the reason I've gained nearly 20 pounds. This is easily the most weight I've ever carried (aside from when I was 9 months pregnant). My clothes don't fit me anymore, which is really distressing. If Aceon is going to continue causing these sorts of problems, then I'll need to look into an alternative medication for my high blood pressure.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about aceon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is aceon still available?

"The Aceon brand name has been discontinued in the U.S. However, if generic versions of this product have been approved by the FDA, there may be generic equivalents available."

Answered by AI

What are the side effects of taking perindopril?

"Dry, tickly cough that does not get better. Cough medicines do not usually help for coughs caused by ACE inhibitors such as perindopril. ... , Feeling dizzy or lightheaded, especially when you stand up or sit up quickly. ... , Headaches. ... , Being sick. ... , Diarrhoea. ... , Mild skin rash. ... , Blurred vision. ... , Muscle cramps."

Answered by AI

What is the generic name for Aceon?

"Perindopril is used to treat high blood pressure and prevent strokes, heart attacks, and kidney problems. This medication is also used to prevent heart attacks in people with a certain type of heart disease (stable coronary artery disease)."

Answered by AI

What class of drug is Aceon?

"Aceon is a prescription medicine used to treat high blood pressure and stable coronary artery disease. It may be used alone or with other medications. Aceon belongs to a class of drugs called ACE inhibitors."

Answered by AI

Clinical Trials for Aceon

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Waitlist Available
Has No Placebo
U Health (+1 Sites)Ziad Zoghby, M.D., M.B.A.Biobeat Technologies Ltd.
Have you considered Aceon clinical trials? We made a collection of clinical trials featuring Aceon, we think they might fit your search criteria.Go to Trials
Image of St Boniface Hospital in Winnipeg, Canada.

Remote Home Monitoring for Heart Attack

18+
All Sexes
Winnipeg, Canada
Heart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Many patients feel anxious and unsure about their recovery, and without enough support, they often end up back in the emergency department (ED). This is an even bigger challenge for people in rural areas, where getting follow-up care can be much harder. Filling these gaps is important to help patients get better and to reduce stress on the healthcare system. In a previous study, the investigators found that extra support made a big difference: only 8% of participants using a digital health tool returned to the ED within 30 days, compared to 22% of participants without it. Now, the investigators want to expand this study across Manitoba to see if digital health tools can help more people recover safely at home. The investigators will compare two types of follow-up care: education only versus education with extra support (like symptom tracking and virtual appointments). The investigators will look at how this affects hospital visits, mental well-being, and healthcare costs. The goal is to create a better support system for people after a heart attack, leading to healthier recoveries, less strain on hospitals, and better care for Manitobans - no matter where they live.
Waitlist Available
Has No Placebo
St Boniface Hospital
Image of Baystate Medical Center in Springfield, United States.

Consent Approaches for Heart Disease Rehabilitation

18+
All Sexes
Springfield, MA
Cardiac Rehabilitation is a lifestyle and exercise program for patients with heart disease. Cardiac Rehabilitation is strongly recommended in guidelines, but only 30% of eligible patients attend. New strategies are needed to help more patients attend cardiac rehabilitation. In this study, the investigators will see if using an $50 incentive, case management, text messages, and physical activity coaching combined into a single intervention will help more patients attend cardiac rehabilitation. In preparation for a larger trial, patients will also be randomly assigned to four different ways of seeking their permission to be in a research study. The investigators will see if these approaches affect how many people participate in the research project. The two main goals of this study is to understand: 1. If the consent approach type impacts participation rates in the research study 2. If the multi-component intervention (case management, financial incentives, text messages, and physical activity coaching) improves cardiac rehabilitation participation within 3 months.
Recruiting
Has No Placebo
Baystate Medical CenterQuinn R Pack, MD, MSc
Image of University of Alabama at Birmingham in Birmingham, United States.

Dietary Interventions for Hypertension

18+
All Sexes
Birmingham, AL
Natriuretic peptides (NPs) are hormones produced by the heart and play an important role in maintaining cardiovascular health and have favorable metabolic benefits. Low NP levels are associated with an increased likelihood of the development of cardiometabolic diseases like diabetes and hypertension. NP levels are known to be highly heritable, with up to half of the differences in NP levels being explained by genetics. The investigators aim to describe the genetic architecture of NPs by examining the genetic variants associated with NPs, and generate and validate a polygenic score (PGS) for NPs. The investigators will use this NP PGS to examine the association of genetically determined NP levels with cardiometabolic and cardiovascular outcomes. The investigators will conduct a genotype-guided physiological clinical trial that aims to assess the genetic factors affecting NP levels and their impact on blood pressure and NP response to saline infusion, high-salt diet, and low-salt diet. These findings will help support personal medicine approaches to lower the increasing burden of hypertension in the United States.
Waitlist Available
Has No Placebo
University of Alabama at BirminghamPankaj Arora, MD, FAHA
Have you considered Aceon clinical trials? We made a collection of clinical trials featuring Aceon, we think they might fit your search criteria.Go to Trials
Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies
Phase 2
Recruiting
Abcentra Investigational Site (+6 Sites)Abcentra
Image of The Ohio State University Wexner Medical Center in Columbus, United States.

Health Coaching for Cardiovascular Disease

18+
All Sexes
Columbus, OH
For patients discharged with a diagnosis of cardiovascular disease coronary artery disease resulting in myocardial infarction and/or congestive heart failure, this study will evaluate if the addition of 12 virtual health coaching sessions over the course of 16 weeks will improve physiological, psychological, and social health outcomes, prove acceptable and satisfactory for these patients with CVD, decrease CVD-related questions and concerns sent to the provider via MyChart, and reduce hospital readmission rates over a 90-day period as compared to patients discharged with the same diagnosis who receive standard post-discharge care. The study will also evaluate the perceptions of physician and advanced practice providers related to the health coach as part of the interprofessional team and the amount of time spent addressing CVD-related patient questions and concerns via MyChart messages.
Waitlist Available
Has No Placebo
The Ohio State University Wexner Medical CenterBeth Steinberg, PhD, RN
Have you considered Aceon clinical trials? We made a collection of clinical trials featuring Aceon, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security